Large Optical Zone Treatment With LADAR Vision For Night Glare Prevention After LASIK

Principal Investigator:  Barrie Soloway, M.D., F.A.C.S.

Enrollment Status:  Ongoing

Overview:  It is a well accepted fact that smaller optical zone treatments in LASIK lead to larger numbers of patients experiencing glare, halos, and other optical anomalies especially during low or dim light settings. This study, performed by Dr. Soloway and Dr. Maw during the last quarter or 1999 showed excellent results in the reduction and elimination of night glare symptoms in patients with pupil sizes greater than 6mm in the dark.

A total of 500 eyes where enrolled in this study. Pupil sizes ranged from 6.0 mm to 8.0 mm. Patient's pre-LASIK eyeglass prescriptions were -1.00 to -9.00 with up to 4 diopters of astigmatism. The Autonomous Technologies LADARVision scanning/tracking laser, and the Moria LSK or Chiron Hansatome keratome was used by Dr. Barrie Soloway on all patients.

Results showed that there were no patient reports of glare, halos, or starburst under dim light conditions at the 1 week or 1 month point attributable to pupil size/ablation zone mismatch. Centration of the ablations were excellent. There were isolated reports of intermittent haze from dryness, though this had resolved in all patients by the 3 month post-operative visit.

TOP

Conclusions:  

• Larger ablation treatment is an effective way to reduce glare due to pupil dilation in dim light
• Additional measurements of corneal pachymetry (thickness) and calculations are required during the pre-operative evaluation to prevent treatments that would thin the cornea beyond its safety point
• The surgeon's ability to produce a large, pupillary centered ablation area (flap) with the microkeratome is crucial to being able to treat these patients
• The Autonomous LADAR Vision laser is able to treat the largest optical zone available in the United States
• The Moria LSK one microkeratome reliable produced the largest, best centered flaps

Other Information:  As the Director of Autonomous' LADARVision Center of Excellence at the New York Eye and Ear Infirmary, Dr. Soloway was the first surgeon in the world to use this laser to treat large optical zones. Results of this landmark study have been accepted for presentation and publication by:

• American College of Eye Surgeons, Buena Vista, FL, March 2000
• Canadian Society of Cataract and Refractive Surgery, Toronto, Canada, April, 2000
• American Society of Cataract and Refractive Surgery, Boston, MA, May, 2000

Contact Information:  Vista Alliance Eye Care Associates Study Coordinator, 160 East 56th Street - 9th Floor, New York, NY 10022, 1-888-821-EYES, or bsolowaymd@pol.net

TOP